Abbott Laboratories (SWX:ABT)
Switzerland · Delayed Price · Currency is CHF | Market Cap | 173.53B |
| Revenue (ttm) | 34.96B |
| Net Income (ttm) | 11.10B |
| Shares Out | n/a |
| EPS (ttm) | 6.35 |
| PE Ratio | 15.63 |
| Forward PE | 22.44 |
| Dividend | 1.96 (1.98%) |
| Ex-Dividend Date | Oct 15, 2025 |
| Volume | n/a |
| Average Volume | n/a |
| Open | n/a |
| Previous Close | 99.00 |
| Day's Range | n/a |
| 52-Week Range | 91.69 - 105.51 |
| Beta | 0.68 |
| RSI | 0.01 |
| Earnings Date | Jan 22, 2026 |
About Abbott Laboratories
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The company provides generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorder, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism,... [Read more]
Financial Performance
In 2024, Abbott Laboratories's revenue was $41.95 billion, an increase of 4.59% compared to the previous year's $40.11 billion. Earnings were $13.35 billion, an increase of 134.19%.
Financial numbers in USD Financial StatementsNews
Interesting ABT Put And Call Options For August 2026
Investors in Abbott Laboratories (Symbol: ABT) saw new options begin trading today, for the August 2026 expiration. One of the key inputs that goes into the price an option buyer is willing to pay, is...
Abbott's Amplatzer Piccolo™ Delivery System Receives FDA Clearance and CE Mark to Optimize Procedures for Premature Babies With a Hole in the Heart
First and only delivery system designed specifically for premature infants with a patent ductus arteriosus (PDA), a life-threatening opening in their heart New delivery system enables precise placemen...
2 Dividend Stocks to Buy for 2026 and Beyond
CVS Health is slowly righting the ship after several challenging years. Abbott Laboratories' strong business should improve thanks to an acquisition.
Abbott Laboratories (ABT) Shares Cross 2% Yield Mark
Looking at the universe of stocks we cover at Dividend Channel, in trading on Wednesday, shares of Abbott Laboratories (Symbol: ABT) were yielding above the 2% mark based on its quarterly dividend (an...
Chris Blumas' Top Picks: Constellation Software, Brookfield Infrastructure & Abbott Labs
Chris Blumas, portfolio manager at Raymond James Investment Counsel, shares his top stock picks to watch in the market.
Abbott Laboratories (ABT) Declares Quarterly Dividend
Abbott Laboratories (ABT) Declares Quarterly Dividend
Abbott Laboratories declares $0.063 dividend
Abbott Laboratories announces $0.063/share dividend with 0.2% yield. Key dates inside.
Start the New Year Off With Passive Income: 3 Dividend Kings to Buy Now
Dividend stocks may boost your portfolio during any market environment. These particular companies have shown their commitment to dividend payments and growth over time.
My Top 10 Stocks to Buy for 2026
Together, these stocks offer you a balanced mix of growth and safety. These companies span a number of industries, and many are leaders in their markets.
Abbott Laboratories (ABT) Expands Board of Directors with New Appointment
Abbott Laboratories (ABT) Expands Board of Directors with New Appointment
Abbott Laboratories (ABT) Boosts Quarterly Dividend by 6.8%
Abbott Laboratories (ABT) Boosts Quarterly Dividend by 6.8%
Abbott Laboratories raises dividend by ~7%
Abbott increases quarterly dividend for 54th consecutive year
Quarterly dividend increased by 6.8% Quarterly dividend payout has increased more than 70% since 2020 408th consecutive quarterly dividend to be paid by Abbott since 1924 ABBOTT PARK, Ill., Dec. 12, 2...
Abbott Laboratories (ABT) Seeks Legal Shield Amid Infant Formula Lawsuits
Abbott Laboratories (ABT) Seeks Legal Shield Amid Infant Formula Lawsuits
High-Quality Compounders With Both Pricing Power And Idiosyncratic Growth
The Touchstone Mid Cap Growth Fund outperformed its benchmark, the Russell Midcap® Growth Index, for the quarter ended September 30, 2025. From a factor perspective, the Fund's overweight exposure to ...
Rep. Richard Dean Dr McCormick Has Bought Up to $390K Worth Of Abbott Laboratories Stock: Here's What You Should Know
Records from December 9, 2025 indicate that Representative Richard Dean Dr McCormick of Georgia made a purchase of Abbott Laboratories (NYSE: ABT), valued between $26,026 and $390,000, with the trans...
Vanguard Group Inc's Strategic Acquisition of Abbott Laboratories Shares
Vanguard Group Inc's Strategic Acquisition of Abbott Laboratories Shares
Abbott's Lingo™ Now on Android™, Expanding Access to Real-Time Glucose Data
Lingo, Abbott's first over-the-counter biowearable, expands to Android devices Continuous glucose monitoring devices help people maintain healthy glucose levels, which are associated with better metab...
Lilly’s GLP-1 Surge Dwarfs Abbott’s Steady Device Growth With 54% Revenue Jump
Abbott Laboratories (NYSE: ABT) and Eli Lilly (NYSE: LLY) just reported Q3 earnings that highlight two fundamentally different healthcare bets. Abbott delivered steady 6.9% revenue growth anchored by ...
University of Wisconsin Wins Abbott and Big Ten's 'We Give Blood' Competition as Campaign Donations Surge 319%, Helping Save Nearly 250,000 Lives
University of Wisconsin wins Abbott and the Big Ten Conference's "We Give Blood" drive, awards $1 million from Abbott to advance student or community health Second year of nationwide blood drive saw a...
Muscles, the New Flex: Abbott Launches Two New Ensure® Max Protein Shakes to Tap into Growing Muscle Health Movement
Aging, nutrition and lifestyle affect muscles, especially after age 40. That's why Matt Ryan, former professional quarterback and MVP, is teaming up with Abbott to drive muscle health awareness with t...
This Top Dividend King Just Became an Even Better Buy
Abbott Laboratories is acquiring Exact Sciences, in a move that will help bolster its diagnostics business. Abbott should expand the reach of Exact Sciences' key products and fuel its innovative engin...
Best Dividend Aristocrats For December 2025
The ProShares S&P 500 Dividend Aristocrats ETF (NOBL) has underperformed the SPDR S&P 500 ETF (SPY) year-to-date, but November shows a reversal. Several Dividend Aristocrats, including CAH, CAT, CHRW,...
ABT Factor-Based Stock Analysis - Peter Lynch
Below is Validea's guru fundamental report for ABBOTT LABORATORIES (ABT). Of the 22 guru strategies we follow, ABT rates highest using our P/E/Growth Investor model based on the published strategy of ...
Eric Shroff Executes Sell Order: Offloads $203K In Abbott Laboratories Stock
Disclosed on November 25, Eric Shroff , Senior Vice President at Abbott Laboratories (NYSE: ABT), executed a substantial insider sell as per the latest SEC filing. What Happened: Shroff's decision to...